the nasdaq composite tumbled by more than 400 points on friday investors meanwhile focused on some notable insider trades when insiders sell shares it indicates their concern in the company’s prospects or that they view the stock as being overpriced either way this signals an opportunity to go short on the stock insider sales should not be taken as the only indicator for making an investment or trading decision at best it can lend conviction to a selling decision below is a look at a few recent notable insider sales for more check out benzingas insider transactions platform   the trade moderna inc director noubar b afeyan sold a total of 10000 shares at an average price of 12240 the insider received around 122 million from selling those shares   what’s happening the european commission recently authorized the conversion of the conditional marketing authorization for modernas spikevax to standard marketing authorization   what moderna does moderna is a commercialstage biotech that was founded in 2010 and had its initial public offering in december 2018 also check this why fear level among us investors is increasing em   the trade eli lilly and company 10 owner lilly endowment inc sold a total of 149264 shares at an average price of 33454 the insider received around 4993 million as a result of the transaction   what’s happening the fda recently granted fast track designation for eli lilly’s tirzepatide for adults with obesity or overweight with weightrelated comorbidities   what eli lilly does eli lilly is a drug firm with a focus on neuroscience endocrinology cancer and immunology have a look at our premarket coverage here   the trade regeneron pharmaceuticals inc svp controller christopher r fenimore sold a total of 1844 shares at an average price of 74900 the insider received around 138 million from selling those shares   what’s happening goldman sachs recently maintained a buy on the stock and raised its price target from 796 from 970   what regeneron pharmaceuticals does regeneron pharmaceuticals discovers develops and commercializes products that fight eye disease cardiovascular disease cancer and inflammation